Christopher Tapper

Christopher Tapper serves as a Board Observer for Carrick Therapeutics, Epitopea, Microbiotica, and Exvastat. In addition to these roles, Christopher Tapper holds the position of Senior Investment Associate and previously served as an Investment Associate at Cambridge Innovation Capital.